Table 1 Association between hsa_circ_0005692 expression and clinical parameters in HCC.

From: CircRNA-5692 inhibits the progression of hepatocellular carcinoma by sponging miR-328-5p to enhance DAB2IP expression

Items

Case No

Mean ± SD

P-value

Gender

Male

76

60.617 ± 24.631

0.102

Female

16

71.906 ± 26.029

 

Age

≤50

35

62.112 ± 21.268

0.889

>50

57

62.868 ± 27.373

 

AFP

<20 ng/ml

25

78.869 ± 29.081

0.001

≥20 ng/ml

67

56.502 ± 20.577

 

HBsAg

Positive

92

  

Negative

0

  

Cirrhosis history

Positive

71

58.131 ± 21.492

0.001

Negative

21

77.624 ± 30.709

 

Tumor size

≤5 cm

55

66.939 ± 24.650

0.042

>5 cm

37

56.101 ± 24.688

 

Tumor number

1

70

65.287 ± 26.671

0.065

≥2

22

53.969 ± 17.079

 

Differentiation

I/II

37

68.733 ± 30.144

0.053

III/IV

55

58.442 ± 20.320

 

Distant metastasis

No

74

65.456 ± 25.831

0.025

Yes

18

50.759 ± 18.013